A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 9, Issue 3, Pages 482-496
Publisher
Wiley
Online
2018-04-14
DOI
10.1002/jcsm.12295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Update on Management of Cancer-Related Cachexia
- (2017) Lindsey J. Anderson et al. Current Oncology Reports
- Cancer- and Chemotherapy-Induced Anemia
- (2017) George M. Rodgers et al. Journal of the National Comprehensive Cancer Network
- Accelerometer-measured dose-response for physical activity, sedentary time, and mortality in US adults
- (2016) Charles E Matthews et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial
- (2016) Mark Ng Tang Fui et al. BMC Medicine
- Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial
- (2016) Marie Sinclair et al. JOURNAL OF HEPATOLOGY
- Number of accelerometer monitoring days needed for stable group-level estimates of activity
- (2016) Dana L Wolff-Hughes et al. PHYSIOLOGICAL MEASUREMENT
- Relationship between patterns of daily physical activity and fatigue in cancer survivors
- (2015) J.G. Timmerman et al. European Journal of Oncology Nursing
- Physical activity and sedentary behavior in breast cancer survivors: New insight into activity patterns and potential intervention targets
- (2015) Siobhan M. Phillips et al. GYNECOLOGIC ONCOLOGY
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
- (2015) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- When and When Not To Use Testosterone for Palliation in Cancer Care
- (2014) Rony Dev et al. Current Oncology Reports
- Muscle wasting in heart failure: An overview
- (2013) Stephan von Haehling et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial
- (2013) E. Del Fabbro et al. SUPPORTIVE CARE IN CANCER
- Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia
- (2012) Basil O. Burney et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer cachexia and anabolic interventions: a case report
- (2012) Edgar L. Dillon et al. Journal of Cachexia Sarcopenia and Muscle
- A Randomized Pilot Study of Monthly Cycled Testosterone Replacement or Continuous Testosterone ReplacementVersusPlacebo in Older Men
- (2011) Melinda Sheffield-Moore et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- The role of testosterone in social interaction
- (2011) Christoph Eisenegger et al. TRENDS IN COGNITIVE SCIENCES
- Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing Study
- (2010) Abdelouahid Tajar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cachexia: A new definition
- (2008) William J. Evans et al. CLINICAL NUTRITION
- Cancer cachexia: Developing multimodal therapy for a multidimensional problem
- (2008) K.C.H. Fearon EUROPEAN JOURNAL OF CANCER
- Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men
- (2007) Andrea D. Coviello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started